MCI WHY DO DIFFERENT MODELS COME TO DIFFERENT CONCLUSIONS?- A STUDY OF 8 COST-EFFECTIVENESS ANALYSES COMPARING COX-2 SPECIFIC INHIBITORS (COXIBS) AND NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)
May 1, 2005, 00:00
10.1016/S1098-3015(10)62578-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)62578-8/fulltext
Title :
MCI WHY DO DIFFERENT MODELS COME TO DIFFERENT CONCLUSIONS?- A STUDY OF 8 COST-EFFECTIVENESS ANALYSES COMPARING COX-2 SPECIFIC INHIBITORS (COXIBS) AND NON STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62578-8&doi=10.1016/S1098-3015(10)62578-8
First page :
Section Title :
Open access? :
No
Section Order :
15